Cnbx Pharmaceuticals Inc. (CNBX) — 10-K Filings
All 10-K filings from Cnbx Pharmaceuticals Inc.. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (2)
-
CNBX Pivots to Cannabinoid Cancer Drugs, Eyes 2026 Clinical Trials
— Dec 1, 2025 Risk: high
CNBX Pharmaceuticals Inc., a clinical-stage company, reported no meaningful revenue from oil and gas exploration, leading to a business model transition in 2014 -
CNBX Pharmaceuticals Files 2024 10-K
— Nov 29, 2024 Risk: medium
CNBX Pharmaceuticals Inc. filed its 2024 10-K report for the fiscal year ending August 31, 2024. The company, formerly known as Cannabics Pharmaceuticals Inc.,
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX